An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Schrödinger, Inc. (Nasdaq: SDGR) has granted non-statutory stock options and restricted stock units (RSUs) to 11 newly hired employees. The stock options have an exercise price of $45.98 per share and a ten-year term, vesting over four years. The RSUs also vest over four years, with 25% vesting after 12 months of continuous service and the balance vesting in equal yearly installments over the three-year period following the first anniversary of the employment start date.
Positive
None.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on June 16, 2023, the company granted (i) non-statutory stock options to purchase 14,325 shares of the company’s common stock to 11 newly hired employees and (ii) restricted stock units (RSUs) with respect to 11,138 shares of the company’s common stock to 11 newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company’s board of directors, and were made as a material inducement to such employees’ acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation.
The stock options have an exercise price of $45.98 per share, equal to the closing price of Schrödinger’s common stock on June 16, 2023. The stock options have a ten-year term and vest over four years, with 25 percent of the shares underlying the option vesting when the employee completes 12 months of continuous service measured from the employment start date and the balance of the shares vesting in a series of successive equal monthly installments of 1/48 of the original number of shares upon the employee’s completion of each additional month of service over the 36-month period following the first anniversary of the employment start date.
The RSUs vest over four years, with 25 percent of such RSUs vesting when such employee completes 12 months of continuous service measured from the vesting commencement date, and the balance of the RSUs vesting in a series of successive equal yearly installments of 1/4 of the original number of RSUs upon each such employee’s completion of each additional year of service over the three-year period following the first anniversary of the employment start date.
The inducement grants are subject to the terms and conditions of award agreements covering the grants and the company’s 2021 Inducement Equity Incentive Plan.
About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The computational platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.
Founded in 1990, Schrödinger has approximately 800 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn, or visit our blog, Extrapolations.com.
How many shares of the company's common stock were granted as stock options?
14,325 shares of the company's common stock were granted as stock options.
What is the exercise price of the stock options?
The exercise price of the stock options is $45.98 per share.
What is the vesting schedule for the stock options?
The stock options vest over four years, with 25% vesting after 12 months of continuous service and the remaining shares vesting in equal monthly installments over the 36-month period following the first anniversary of the employment start date.
How many shares of the company's common stock were granted as RSUs?
11,138 shares of the company's common stock were granted as RSUs.
What is the vesting schedule for the RSUs?
The RSUs vest over four years, with 25% vesting after 12 months of continuous service and the remaining RSUs vesting in equal yearly installments over the three-year period following the first anniversary of the employment start date.
